Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

NewsBreak: FDA in Criminal Vaping Probe; 530 Sickened

Published 09/19/2019, 12:31 PM
Updated 09/19/2019, 12:41 PM
© Reuters.

Investing.com - The U.S. Food and Drug Administration said Thursday its enforcement arm is involved in a criminal probe of e-cigarettes, The Washington Post reported.

  • The FDA said 530 people have suffered an as-yet-unknown vaping-related illness.

  • The criminal probe had started earlier in the summer, when the illnesses were first reported, the Post said.
    • Philip Morris International (NYSE:PM) shares were up 0.3% midday, while Altria Group (NYSE:MO) dropped 2%.

    Latest comments

    Why not sue the liquor companies that are ****people as well?
    why I'm not surprise. The cake was getting smaller for Philip Morris.
    What about people who really are ill from othr unsafe prqctices and now its all the blam for the vape industry?
    Dont vape street ****** How many people died from cigarettes this year and opiots?
    they pretend not to know the culprit...its the fact that you cannot smoke Vitamin E. it turns into cyanide when vaped. that additive is in only a few 3rd party brands. Not in the reputable ones!!!!
    let's just forget about the opioid crisis though right?
    So !
    Smoking batteries
    Thumbnail will cause health problems CHANGE IT
    Lol true!
    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.